Skip to content

Effects of two physiotherapeutic interventions in women with loss of urine following stroke

Effects of tibial and parasacral nerve stimulation techniques in women with hyperactive neurogenic bladder after stroke.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2bn2z4
Enrollment
Unknown
Registered
2018-12-11
Start date
2018-11-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Urinary Incontinence.

Interventions

The sample size will be 22 subjects per group, totaling 44 volunteers. Treatment of both groups will be done twice a week, totaling 12 sessions. The choice of this periodicity was based on Fischer-Sgr
Other
E02.331.800

Sponsors

Universidade Federal de Uberlândia
Lead Sponsor
Universidade Federal de Uberlândia
Collaborator
Faculdade de Educação Fisica e Fisioterapia (FAEFI)
Collaborator

Eligibility

Sex/Gender
Female
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria of the patients in this research are: age between 40 and 70 years; carriers of ischemic or hemorrhagic stroke; who has more than one month post AVC with overactive bladder; without infection in the urinary tract and bladder tumor, without cognitive deficit (mini-mental> 18).

Exclusion criteria

Exclusion criteria: The criteria for excluding patients in this research are pregnant women, women who already had urinary incontinence before the stroke episode, women who have pacemaker implantation and taking neurogenic bladder medications.

Design outcomes

Primary

MeasureTime frame
In order to assess the impact of the UI, the ICIQ-SF (International Consultation on Incontinence Questionnaire-Short Form), which is simple, brief, with four questions, will be used. (Fischer-Sgrott et al, 2009) (Taminini JTN), which is the most commonly used questionnaire, , et al 2004) .22,21 To verify this outcome, the questionnaire will be applied before and after the intervention, which will measure the difference between the values of the initial questionnaire and the final one, to see if there has been improvement in the form of comparison of numerical data.

Secondary

MeasureTime frame
Measure the number of urine losses. To evaluate urinary habit, the Urinal Dose will be used to quantify the diurnal and nocturnal voiding frequency and the number of urinary losses. The volunteers will be instructed to complete for three days in a table provided by the researchers the number of toilet visits and the number of urinary losses (Marques AA, et al, 2009). To verify this outcome the voiding diary will be evaluated before intervention and after the end of it, which will be measured the difference of the values of the initial voiding diary to the end, to see if there was improvement in comparison of numerical data.;To measure the quality of life of these women after stroke with UI. To evaluate quality of life (QOL), the World Health Organization Quality of Life (WHOQOL-BREF) will be used to develop a QOL concept with positive points (medication mobility, role performance, contentment) and (fatigue, pain, drug dependence, and negative feelings). (COSTA, RC, 2013). The questionnaire consists of 26 questions, with five options sorted into a value ranging from 1 to 5 for each response, with 24 questions representing one of the four domains that make up the original instrument and two general quality of life issues. (VIEGAS, K et al, 2009). The WHOQOL-bref QOL general questionnaire is divided into four domains: physical, psychological, social and environmental. Each specific domain is evaluated according to the values obtained through the WHOQOL-bref, where the higher the score obtained (maximum = 100), the better the QoL related to that domain. (Knorst, MR, et al, 2011). In order to verify this outcome, the quality of life questionnaire will evaluate before and after the intervention, which will measure the difference between the initial and final values, to see whether there was improvement in comparison of numerical data.

Countries

Brazil

Contacts

Public ContactThais;Vanessa Candido;Baldon

Universidade Federal de Uberlândia ;Universidade Federal de Uberlândia

thaisalvescandido@gmail.com;pereiravans@gmail.com+55-34-32182901;+55-034-32182901

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 17, 2026